Spirocycles
    13.
    发明授权
    Spirocycles 失效
    螺旋

    公开(公告)号:US5382587A

    公开(公告)日:1995-01-17

    申请号:US85573

    申请日:1993-06-30

    摘要: Spirocycles of the general structural formulae: ##STR1## wherein: X is O, CH.sub.2 or SO.sub.m ;R.sup.1 is AlkylSO.sub.2 NH--, AlkylO--, AlkylSO.sub.2 --, AlkylCONH--, or NO.sub.2 --;R.sup.2 is --H, --OAlkyl, or --Alkyl;R.sup.3 is --NHCOCH.sub.2 SO.sub.m Phenyl, --NHCOCH.sub.2 SO.sub.m Alkyl,--NHCOC(CH.sub.3).sub.2 OH, or NHSO.sub.2 Alkyl;R.sup.4 and R.sup.5 are --H, or --Alkyl;R.sup.6 is ##STR2## R.sup.7 is --H, --CN, --NHSO.sub.2 Alkyl, --Br, --OAlkyl, --NH.sub.2, --NO.sub.2, --NHCOAlkyl, or NHCONHAlkyl;R.sub.8 is --H, --OH, --CN, --OAlkyl, --CONHAlkyl, --NHSO.sub.2 Alkyl, --NHCOAlkyl, --SO.sub.m Alkyl, or --CO.sub.2 Alkyl;and m is 0-2; or a pharmaceutically acceptable salt, hydrate or crystal form thereof; which are Class III antiarrhythmic agents.

    摘要翻译: 一般结构式的螺环:其中:X为O,CH 2或SO m; R1是烷基SO2NH-,烷基O-,烷基SO2-,烷基CONH-或NO2-; R2是-H,-OA烷基或 - 烷基; R3是-NHCOCH2SOm苯基,-NHCOCH2SO2烷基,-NHCOC(CH3)2OH或NHSO2烷基; R4和R5是-H或 - 烷基; R 6是-H,-CN,-NHSO 2烷基,-Br,-OA烷基,-NH 2,-NO 2,-NHCO烷基或NHCONHA烷基; R8是-H,-OH,-CN,-OA烷基,-CONHA烷基,-NHSO2烷基,-NHCO烷基,-SO2烷基或-CO2烷基; m为0-2; 或其药学上可接受的盐,水合物或晶体形式; 这是III类抗心律失常药。